AFX-001

N/A

Report date: 2023/04/24 14:30:08

Base Information

Drug NameAFX-001
Drug Alias NameAFX-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffyXell Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAffyXell Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A